Eric Baetscher
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eric Baetscher has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
Alexander R. Guimaraes
Department of Diagnostic Radiology, Oregon Health & Science University, Portland, OR 97239
1 shared publication- Alexandra Q. Bartlett
Oregon Health & Science University 1 Department of Surgery Portland, Oregon
1 shared publication - Andrea E. DeBarber
Oregon Health and Science University
1 shared publication - Christopher D. Kroenke
Division of Neuroscience, Oregon National Primate Research Center Oregon Health & Science University Beaverton Oregon USA
1 shared publication Connor Hilts
Advanced Imaging Research Center Oregon Health and Science University Portland Oregon USA
1 shared publicationEmily Katsnelson
Berkovich MS Center and Research Institute West Hollywood California USA
1 shared publication
Latest Publications
- Open Access
- 25 November 2025
- Published by Wiley in Addiction Biology
- Vol. 30 (12) , e70101
Escalation of Ethanol Drinking in Mice Is Associated With Neurochemical Changes in the Dorsal Striatum
Prior studies indicate that a bias towards excitation in the excitatory/inhibitory balance occurs in the dorsal striatum as a result of chronic heavy alcohol use. However, investigations of the dorsal striatum by noninvasive means, such as magnetic resonance spectroscopy (MRS) in vivo, have been lacking. In this study, 49 mice (27 female) on a C57BL/6J genetic background were subject to a chronic intermittent ethanol and forced swim stress (CIE‐FSS) procedure. For each mouse, MRS data were acquired at two timepoints from a single voxel covering the dorsal striatum bilaterally. The baseline MRS timepoint occurred in an ethanol naïve state. Ethanol drinking for all mice consisted of 1‐h/day access to one bottle of 15% ethanol, for 5 days/week. After a 6‐week ethanol drinking acclimation period, mice were assigned to four experimental groups: air and no stress, air and stress, EtOH vapour and no stress, and EtOH vapour and stress. Mice then underwent four cycles of CIE‐FSS, each cycle consisted of 1 week of vapour (air or ethanol) followed by 1 week of either 10 min of FSS swim stress or no swim stress, and 1‐h access to 15% ethanol. A follow‐up MRS timepoint occurred at the conclusion of the 14‐week CIE‐FSS protocol, after at least 43 h of abstinence from ethanol. Whole‐cohort ethanol drinking increased from a mean ± SEM of 1.51 ± 0.11 g/kg at Week 1, to a mean of 3.15 ± 0.13 g/kg at Week 14. Robust increases in several neurochemicals were observed between baseline and follow up, with the largest increases found for glutamate, glutamine, taurine, and creatine. Two sets of analysis on MRS data were performed: (1) assessing effects of experimental group (CIE, FSS and/or sex) on striatal neurochemistry and (2) investigating correlations between longitudinal changes in ethanol drinking and changes in neurochemical concentrations. Striatal neurochemical concentrations exhibited CIE‐FSS group effects (1), notably EtOH vapour exposure significantly reduced lactate concentrations at follow up. The change in glutamate between baseline and follow up was significantly lower in EtOH vapour exposed mice. Changes in the glutamate/glutamine ratio were markedly reduced in the EtOH vapour condition. In our correlational analysis (2) of changes in drinking versus changes in neurochemical concentrations from baseline to follow up, we found that female mice have strong positive linear correlations between the change in ethanol drinking and the changes in concentration of glutamate, glutamine, taurine, myo‐inositol and creatine. In male mice, inverse correlations were found between changes in drinking and changes in glutamate, taurine and creatine concentrations. Additionally, the change in cerebral ventricle volume was found to correlate with the change in ethanol drinking, but ventricular volume change was not significantly affected by CIE or FSS. Together, the observed effects of CIE on MRS outcomes in dorsal striatum and the correlations between neurochemical changes and drinking behaviour substantiate the importance of the dorsal striatum in escalating ethanol consumption and are promising evidence for the utility of MRS to detect behaviourally relevant changes in heavy ethanol drinking phenotypes.
- 25 November 2025
- Published by Wiley in Addiction Biology
- Vol. 30 (12) , e70101
Open AccessEscalation of Ethanol Drinking in Mice Is Associated With Neurochemical Changes in the Dorsal Striatum
Prior studies indicate that a bias towards excitation in the excitatory/inhibitory balance occurs in the dorsal striatum as a result of chronic heavy alcohol use. However, investigations of the dorsal striatum by noninvasive means, such as magnetic resonance spectroscopy (MRS) in vivo, have been lacking. In this study, 49 mice (27 female) on a C57BL/6J genetic background were subject to a chronic intermittent ethanol and forced swim stress (CIE‐FSS) procedure. For each mouse, MRS data were acquired at two timepoints from a single voxel covering the dorsal striatum bilaterally. The baseline MRS timepoint occurred in an ethanol naïve state. Ethanol drinking for all mice consisted of 1‐h/day access to one bottle of 15% ethanol, for 5 days/week. After a 6‐week ethanol drinking acclimation period, mice were assigned to four experimental groups: air and no stress, air and stress, EtOH vapour and no stress, and EtOH vapour and stress. Mice then underwent four cycles of CIE‐FSS, each cycle consisted of 1 week of vapour (air or ethanol) followed by 1 week of either 10 min of FSS swim stress or no swim stress, and 1‐h access to 15% ethanol. A follow‐up MRS timepoint occurred at the conclusion of the 14‐week CIE‐FSS protocol, after at least 43 h of abstinence from ethanol. Whole‐cohort ethanol drinking increased from a mean ± SEM of 1.51 ± 0.11 g/kg at Week 1, to a mean of 3.15 ± 0.13 g/kg at Week 14. Robust increases in several neurochemicals were observed between baseline and follow up, with the largest increases found for glutamate, glutamine, taurine, and creatine. Two sets of analysis on MRS data were performed: (1) assessing effects of experimental group (CIE, FSS and/or sex) on striatal neurochemistry and (2) investigating correlations between longitudinal changes in ethanol drinking and changes in neurochemical concentrations. Striatal neurochemical concentrations exhibited CIE‐FSS group effects (1), notably EtOH vapour exposure significantly reduced lactate concentrations at follow up. The change in glutamate between baseline and follow up was significantly lower in EtOH vapour exposed mice. Changes in the glutamate/glutamine ratio were markedly reduced in the EtOH vapour condition. In our correlational analysis (2) of changes in drinking versus changes in neurochemical concentrations from baseline to follow up, we found that female mice have strong positive linear correlations between the change in ethanol drinking and the changes in concentration of glutamate, glutamine, taurine, myo‐inositol and creatine. In male mice, inverse correlations were found between changes in drinking and changes in glutamate, taurine and creatine concentrations. Additionally, the change in cerebral ventricle volume was found to correlate with the change in ethanol drinking, but ventricular volume change was not significantly affected by CIE or FSS. Together, the observed effects of CIE on MRS outcomes in dorsal striatum and the correlations between neurochemical changes and drinking behaviour substantiate the importance of the dorsal striatum in escalating ethanol consumption and are promising evidence for the utility of MRS to detect behaviourally relevant changes in heavy ethanol drinking phenotypes.
- Open Access
- 23 September 2025
- Published by Wiley in Annals of Clinical and Translational Neurology
- Vol. 13 (1) , 85-96
Annual 12‐Week Dosing Gap of Natalizumab: Clinical Efficacy, Blood Biomarkers, and CSF Cell Composition
Objective: Natalizumab (NTZ) is a highly effective therapy for multiple sclerosis (MS); however, its use is limited by the risk of a rare potentially severe opportunistic brain infection, progressive multifocal leukoencephalopathy (PML). Alternative dosing strategies are evaluated to reduce PML risk while still maintaining efficacy, which include extending the dosing interval (EID) or a lesser‐known annual dosing gap (aGAP), which is the focus of this prospective observational single‐site cohort study. We evaluated whether aGAP affects the efficacy of NTZ, which biomarkers could be useful for a personalized dosing strategy, and potential cellular mechanisms that might contribute to reducing the risk of PML during aGAP. Methods: Clinical assessments, quantifications of NTZ, neurofilament light chain (NfL), and soluble vascular cell adhesion molecule‐1 (sVCAM‐1) were performed for ten study participants of a clinical trial (NCT04048577); CSF single‐cell RNA‐sequencing data from nine participants (15 samples) were analyzed together with 48 healthy and 35 MS controls. Results: Although NTZ serum levels were decreased below EID levels and sVCAM‐1 levels were increased, aGAP was not associated with MS activity as measured by EDSS and MRI. After aGAP, while CSF cell counts remained stable, the CSF immune cell composition changed and NfL values were increased 3 months post gap. CSF proportions of CD4, CD8, and natural killer cell subsets increased towards levels of untreated MS patients, while B‐cell proportions remained unchanged. Interpretation: The differential CSF composition associated with sVCAM‐1 serum level changes suggests that selective immune cell trafficking may occur during aGAP, potentially contributing to PML prevention.
- 23 September 2025
- Published by Wiley in Annals of Clinical and Translational Neurology
- Vol. 13 (1) , 85-96
Open AccessAnnual 12‐Week Dosing Gap of Natalizumab: Clinical Efficacy, Blood Biomarkers, and CSF Cell Composition
Objective: Natalizumab (NTZ) is a highly effective therapy for multiple sclerosis (MS); however, its use is limited by the risk of a rare potentially severe opportunistic brain infection, progressive multifocal leukoencephalopathy (PML). Alternative dosing strategies are evaluated to reduce PML risk while still maintaining efficacy, which include extending the dosing interval (EID) or a lesser‐known annual dosing gap (aGAP), which is the focus of this prospective observational single‐site cohort study. We evaluated whether aGAP affects the efficacy of NTZ, which biomarkers could be useful for a personalized dosing strategy, and potential cellular mechanisms that might contribute to reducing the risk of PML during aGAP. Methods: Clinical assessments, quantifications of NTZ, neurofilament light chain (NfL), and soluble vascular cell adhesion molecule‐1 (sVCAM‐1) were performed for ten study participants of a clinical trial (NCT04048577); CSF single‐cell RNA‐sequencing data from nine participants (15 samples) were analyzed together with 48 healthy and 35 MS controls. Results: Although NTZ serum levels were decreased below EID levels and sVCAM‐1 levels were increased, aGAP was not associated with MS activity as measured by EDSS and MRI. After aGAP, while CSF cell counts remained stable, the CSF immune cell composition changed and NfL values were increased 3 months post gap. CSF proportions of CD4, CD8, and natural killer cell subsets increased towards levels of untreated MS patients, while B‐cell proportions remained unchanged. Interpretation: The differential CSF composition associated with sVCAM‐1 serum level changes suggests that selective immune cell trafficking may occur during aGAP, potentially contributing to PML prevention.
- Open Access
- 22 November 2021
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 118 (48)
Pregnancy and weaning regulate human maternal liver size and function
Significance: These human data are consistent with reproductive control of liver size and function in women and concur with recent observations in rodents, suggesting a conserved liver biology. The question of whether this described liver biology has implications for maternal health during pregnancy or sex-specific risk for liver disease remains to be determined. However, our evidence suggestive of weaning-induced liver involution in women may lead to improved understanding of the high rates of liver metastasis observed in young postpartum breast cancer patients.
- 22 November 2021
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 118 (48)
Open AccessPregnancy and weaning regulate human maternal liver size and function
Significance: These human data are consistent with reproductive control of liver size and function in women and concur with recent observations in rodents, suggesting a conserved liver biology. The question of whether this described liver biology has implications for maternal health during pregnancy or sex-specific risk for liver disease remains to be determined. However, our evidence suggestive of weaning-induced liver involution in women may lead to improved understanding of the high rates of liver metastasis observed in young postpartum breast cancer patients.